首页 | 官方网站   微博 | 高级检索  
     

老年急性非早幼粒细胞白血病NPM1及FLT3-ITD基因突变特征及临床意义
引用本文:肖 蓉,姜 涛,万纯黔,李 慧,李成龙,车菲菲,陈 姣,黄晓兵,王春森,王晓冬.老年急性非早幼粒细胞白血病NPM1及FLT3-ITD基因突变特征及临床意义[J].现代肿瘤医学,2019,0(11):1984-1988.
作者姓名:肖 蓉  姜 涛  万纯黔  李 慧  李成龙  车菲菲  陈 姣  黄晓兵  王春森  王晓冬
作者单位:四川省医学科学院 四川省人民医院血液科,四川 成都 610072
摘    要:目的:探讨老年急性非早幼粒细胞白血病(non-acute promyelocytic leukemia,non-APL)NPM1及FLT3-ITD基因突变特征及临床意义。方法:回顾性分析本院2011年1月至2018年6月接受NPM1、FLT3-ITD基因突变检测的98例老年non-APL患者临床资料,统计NPM1、FLT3-ITD基因突变阳性率,分析不同核型non-APL患者NPM1、FLT3-ITD基因突变情况,并比较 NPM1/FLT3-ITD基因突变阳性与阴性患者性别、年龄、白细胞、血小板、血红蛋白、骨髓原始细胞、CD34+、CD117+的关系。结果:NPM1基因突变阳性20例,占20.41%;FLT3-ITD基因突变阳性15例,占15.31%;NPM1、FLT3-ITD基因突变双阳性5例,占5.10%。正常核型38例,占38.78%,正常核型患者NPM1、FLT3-ITD基因突变阳性率及双阳性率均显著高于异常核型者(P<0.05)。NPM1基因突变阳性患者白细胞计数、血小板计数均显著大于NPM1基因突变阴性者,CD34+比例显著小于NPM1基因突变阴性者(P<0.05);FLT3-ITD基因突变阳性患者白细胞、骨髓原始细胞均显著大于FLT3-ITD基因突变阴性者(P<0.05)。NPM1基因突变阳性患者1疗程CR率、总CR率均显著高于NPM1基因突变阴性者(P<0.05);FLT3-ITD基因突变阳性患者1疗程CR率、总CR率均显著低于FLT3-ITD基因突变阴性者(P<0.05)。结论:对老年non-APL患者行FLT3-ITD及NPM1基因突变检测,可指导临床治疗及疗效评估。

关 键 词:急性非早幼粒细胞白血病  FLT3-ITD  NPM1  基因突变  特征

Characteristics and clinical significance of NPM1 and FLT3-ITD gene mutations in elderly patients with non-acute promyelocytic leukemia
Xiao Rong,Jiang Tao,Wan Chunqian,Li Hui,Li Chenglong,Che Feifei,Chen Jiao,Huang Xiaobing,Wang Chunsen,Wang Xiaodong.Characteristics and clinical significance of NPM1 and FLT3-ITD gene mutations in elderly patients with non-acute promyelocytic leukemia[J].Journal of Modern Oncology,2019,0(11):1984-1988.
Authors:Xiao Rong  Jiang Tao  Wan Chunqian  Li Hui  Li Chenglong  Che Feifei  Chen Jiao  Huang Xiaobing  Wang Chunsen  Wang Xiaodong
Affiliation:Department of Hematology,Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital,Sichuan Chengdu 610072,China.
Abstract:Objective:To investigate the characteristics and clinical significance of NPM1 and FLT3-ITD gene mutations in elderly patients with non-acute promyelocytic leukemia (non-APL).Methods:The clinical data of 98 elderly patients with non-APL who were tested for FLT3-ITD and NPM1 mutations in the hospital during the period from January 2011 to June 2018 were retrospectively analyzed.The positive rates of NPM1 and FLT3-ITD mutations were statistically analyzed,and FLT3-ITD and NPM1 mutations in patients with different karyotypes were analyzed.The gender,age,white blood cell,platelet,hemoglobin,bone marrow blasts,CD34+,CD117+ and curative effect were compared between NPM1/FLT3-ITD gene mutation positive and negative patients.Results:NPM1 gene mutation was positive in 20 cases,accounting for 20.41% while FLT3-ITD gene mutation was positive in 15 cases,accounting for 15.31%.NPM1 and FLT3-ITD gene mutations were positive in 5 cases,accounting for 5.10%.There were 38 cases with normal karyotype,accounting for 38.78%.The positive rates of NPM1 and FLT3-ITD gene mutations and double positive rate in patients with normal karyotype were significantly higher than those in patients with abnormal karyotype (P<0.05).The white blood cell and platelet counts in NPM1 gene mutation positive patients were significantly greater and the ratio of CD34+ was significantly lower than that in NPM1 gene mutation negative patients (P<0.05).White blood cells and bone marrow blasts in FLT3-ITD gene mutation positive patients were significantly more than those in FLT3-ITD gene mutation negative patients (P<0.05).The CR after 1 course of treatment and total CR of NPM1 gene mutation positive patients were significantly higher than those of NPM1 gene mutation negative patients (P<0.05).The CR after 1 course of treatment and total CR of FLT3-ITD gene mutation positive patients were significantly lower than those of FLT3-ITD gene mutation negative patients (P<0.05).Conclusion:The detection of FLT3-ITD and NPM1 gene mutations in elderly patients with non-APL can guide clinical treatment and evaluation of curative effect.
Keywords:non-acute promyelocytic leukemia  FLT3-ITD  NPM1  gene mutation  characteristics
点击此处可从《现代肿瘤医学》浏览原始摘要信息
点击此处可从《现代肿瘤医学》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号